Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT02163993
Eligibility Criteria:
Inclusion Criteria:
* Participants with a history of migraine of at least 1 year prior to enrollment.
* Migraine onset prior to age 50.
Exclusion Criteria:
* Current enrollment in, or discontinuation within the last 30 days from, a clinical trial involving any investigational drug or device.
* Current use or any prior exposure to any CGRP antibody, any antibody to the CGRP receptor, or antibody to nerve growth factor (NGF).
* History of migraine subtypes including hemiplegic migraine, ophthalmoplegic migraine, and basilar-type migraine.
* Have a history or presence of other medical illness that indicates a medical problem that would preclude study participation.
* Failure to respond to more than two adequately dosed effective migraine prevention treatments.
* Evidence of significant active psychiatric disease, in the opinion of the investigator.
* Women who are pregnant or nursing.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02163993
Study Brief:
Protocol Section:
NCT02163993